跳至主要内容
临床试验/NCT07146035
NCT07146035尚未招募不适用

Feasibility of a Newly Developed Ostomy Prototype

Coloplast A/S1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年8月25日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Coloplast A/S
入组人数
10
试验地点
1
主要终点
To test the system performance of the prototype.

研究概览

简要总结

Despite the development of better stoma products, individuals with intestinal stomas can experience leakage problems, which negatively affect their quality of life. To overcome this, Coloplast are in the process of developing a leakage measurement device. Each participant will undergo five 24-hour test periods over three weeks, wearing the prototype around the stoma (Test) and on the opposite side (Control).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Has given written informed consent Is at least 18 years old Has full legal capacity Is able (assessed by the investigator) and willing to adhere to study procedures during study duration.
  • •Has had an ileostomy for at least 30 days. Has been self-managing their own ostomy product for at least 14 days. Has experienced leakage under the baseplate at least 3 times within the past 2 weeks.
  • •Is able to fit one of the two test product sizes (Ø50mm or Ø60mm). Uses a flat baseplate Is willing to change their baseplate daily Has intact peristomal skin (assessed by the investigator) Is able to use a smartphone with camera

排除标准

  • •Is participating in any other clinical investigation during this investigation Has previously participated or completed this investigation Has a known hypersensitivity towards the prototype used in the investigation Is pregnant Is breast feeding Has more than one ostomy synchronously Has ongoing non-healed abdominal wounds Has planned MR scans during the 24-hour test recording

研究组 & 干预措施

Investigation (one armed study)

Experimental

干预措施: CP369 Feasibility of a newly developed ostomy prototype (only one intervention) (Device)

结局指标

主要结局

To test the system performance of the prototype.

时间窗: 3 weeks from enrollment to end of treatment

次要结局

未报告次要终点

研究者

发起方
Coloplast A/S
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验